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Abstract: We analyzed 218 strains of methicillin-resistant Staphylococcus aureus (MRSA) 
isolated from the septicemia patients in a geriatric hospital for 25 years. These strains were 
classified into 11 major DNA types, A through K, and 27 minor types. The strains belonging to 
group A and B isolated before 1990 were susceptible to imipenem (IPM), fluoroquinolone, and 
most other antibiotics tested, except that they were markedly resistant to gentamicin. Strains 
mostly isolated in 1985 and thereafter were classified into group C through K, and they were 
mainly resistant to IPM, fluoroquinolones, and clindamycin. Analysis of the MRSA marker gene, 
staphylococcal cassette chromosome mec (SCCmec), of these strains revealed that the strains 
in groups A and B had mainly type IV and type I, respectively, and that strains in groups C 
through J had mainly type II. These results suggested that the strains holding type II SCCmec 
were resistant to IPM, fluoroquinolone, and clindamycin and they were dominant-resistant type 
after late 1980s. The antibiotic resistance profiles of MRSA dramatically changed during late 
1980s, and these were correlated with the SCCmec types. The lesson from this study would 
be that consistent execution of surveillance study is needed to update the resistant profiles.
Keywords: methicillin-resistant Staphylococcus aureus, DNA typing, antibiotic resistance, 
survey, geriatric hospital
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a major causative agent of 
nosocomial and community-acquired infections, which bring about variety of clinical 
symptoms, including endocarditis, osteomyelitis, pneumonia, toxic shock syndrome, 
food poisoning, carbuncles, and boils.1 The nosocomial outbreak of MRSA was 
first reported in England in 1961 and that had been reported all over the world soon 
after.2–4 The isolation frequency of MRSA strains dramatically increased in ∼1960s 
thereafter.
Hospitalization of geriatric patients in general hospital due to bloodstream infection 
(BSI) has been increasing from 1980s through 2000s in the United States.5–7 The 
major pathogenic organisms causing septicemia are Escherichia coli, Staphylococci, 
Streptococci, and Pneumococci.6 Overall BSI-associated mortality has been reported 
to be 30%–60% in elderly patients, and the highest mortality rate is associated with 
S. aureus infection.7–9 Associated risk factors causing BSI are high incidence of 
comorbid conditions, such as chronic heart or lung disease, hypertension, and   diabetes 
mellitus.6,7 It is increasingly reported in the health care-associated acquisition of MRSA 





For the monitoring of antibiotic susceptibilities, it 
is helpful to determine the minimum growth inhibitory 
  concentration (MIC) of antibiotics. More recently, the gene(s) 
responsible for the resistance, such as the staphylococcal 
cassette chromosome mec (SCCmec) element, have been 
analyzed.10 It is also powerful to use the molecular group-
ing technique to classify MRSAs into subgroup by the 
  pulsed-field gel electrophoresis (PFGE) of the chromosomal 
DNA; such study revealed the presence of highly virulent 
MRSA, such as USA300. The studies contribute both to the 
control of nosocomial infection and to a better understanding 
of the evolutionary relationships among MRSA.11–13
The data lacking is a long-term trace of antibiotic-
resistant MRSA in a geriatric hospital. To analyze the fate 
of antibiotic-resistant MRSA, we collected MRSAs from 
the patients in a geriatric hospital through two decades. 
And they were subjected to the SCCmec typing, the anti-
biotic susceptibility test, and the DNA typing. The results 
revealed that MRSAs with unique DNA type were carried 
into the hospital probably with incoming patients and 




A total of 218 strains of MRSA were collected from the 
patients in a single geriatric hospital in Tokyo from 1978 
through 2002. Information on patient’s background and 
clinical symptoms could not be collected due to the law 
on the protection of privacy regarding the processing of 
personal data. All the S. aureus strains were isolated from 
the blood specimens on the mannitol–NaCl agar plate, and 
the colonies grown on the medium were subjected to the 
methicillin and oxacillin susceptibility test, the mecA gene 
amplification by Tsuchizaki et al method.14 The mecA-
positive strains with MIC of methicillin $16 mg/L or that of 
oxacillin $4 mg/L were classified as MRSA. These strains 
were kept frozen at −80°C in the brain heart infusion broth 
(Nippon Becton   Dickinson, Tokyo, Japan) supplemented 
with 40% glycerol.
Antibiotics
Imipenem (IPM) was a gift from Banyu Pharmaceutical Co 
(Tokyo, Japan). Arbekacin (ABK) was purchased from Meiji 
Seika Kaisha (Tokyo, Japan). Gentamicin (GM), minocycline 
(MINO), rifampicin (RFP), and sulfamethoxazole were 
  purchased from Wako Pure Chemical Industries (Osaka, 
Japan). Ciprofloxacin (CPFX), clindamycin (CLDM), 
trimethoprim, teicoplanin (TEIC), and linezolid (LZD) 
were a gift from Bayer Yakuhin (Osaka, Japan),   Dainippon 
  Sumitomo Pharma Co (Osaka, Japan), Shionogi and Co 
(Osaka, Japan), Astellas Pharmaceutical Inc (Tokyo, 
Japan), and Pfizer Japan Inc (Tokyo, Japan), respectively. 
  Vancomycin (VCM) was purchased from Sigma-Aldrich 
(Saint Louis, MO).
Determination of the MIc of antibiotic
The MIC of the antibiotics was determined by the agar 
  dilution method according to the Clinical and Labora-
tory Standards Institute (CLSI) guideline as described 
previously.15
Typing of the Sccmec gene
Multiplex polymerase chain reaction (PCR) was carried out 
using a pair of primers according to the method of Oliveira 
and de Lencastre.16 The DNA polymerase used was Phusion 
High-Fidelity DNA polymerase (Finnzymes Oy, Espoo, 
Finland). The reaction mixture contained the formula recom-
mended for the DNA polymerase. The thermal cycler was 
set to 95°C for 30 sec, a total 30 cycles of 98°C for 10 sec, 
57°C for 10 sec, and 72°C for 15 sec, and 72°C for 5 min 
at the end using a Gene Amp PCR System 9700 thermal 
cycler (Applied Biosystems Japan, Tokyo, Japan). The 
products were subjected to electrophoresis in 4% agarose 
gel in EDTA buffer at 100 V for 80 min. A 100-bp DNA 
ladder (New England Biolabs, Hitchin, UK) was used as a 
size maker. Since on time PCR over 25 years is not practical, 
all the samples were kept frozen at −80°C and subjected to 
PCR within about half a year in 2007.
PFGe
Chromosomal DNA was extracted from the MRSA cells and 
was digested with SmaI according to the method described 
by Bannerman et al.17 The DNA plugs sliced at a thickness 
of 1–4 mm were placed in 170 µL of a solution containing 
10 units of SmaI, 20 µL of T-buffer (0.1 M tris-HCl, pH 8.0, 
700 mM MgCl2, 0.2 M KCl, 700 mM 2-mercaptoethanol), 
and 20 µL of 0.1% bovine serum albumin. The mixture 
was incubated at 25°C for 4 h. Samples were loaded on 
1%   agarose gel prepared in 0.5 × TBE buffer containing 
44.5 mM tris, 44.5 mM boric acid, and 1 mM EDTA pH 8.0. 
The wells were sealed with 1% agarose in the same buffer. 
PFGE was carried out with a CHER-DRIII electrophoresis 
cell   (Bio-Rad, Hercules, CA) at 6 V/cm for 20 h at 14°C 
with initial and final pulses conducted for 5.3 and 34.9 sec, 




MrSA in a geriatric hospital
Hayward, CA) according to the manufacturer’s manual and 
visualized under a 254-nm UV light.
The digital images were analyzed with PDQuest 
  software (version 4.5; Bio-Rad), according to the unweighted 
pair-group matching analysis clustering algorithm. The 
strains with over ∼90% identity were classified into the same 
group. Those groups that consisted of less than four isolates 
were excluded from further study. Similar to PCR, PFGE of 
all strains was carried out in a few months.
Results
Grouping of MrSAs
Because all the MRSA strains subjected to this study were 
collected through two decades, 1978–2002, they might be 
suitable for the model study of chronological changes of 
MRSA with regard to antibiotic susceptibility, DNA type, 
and the MRSA marker gene. All 218 strains were subjected 
to PFGE fingerprinting, and 11 major groups (more than 
five strains per group) and 27 minor groups (less than four 
strains per group) were found (Figure 1). Group A through K 
was aligned along chronologic order of sampling (Figure 2). 
Strains isolated from 1978 through 1989 were classified into 
group A and B. Strains isolated ∼1985 through 2002 were 
classified into the group C through K. Remaining 47 strains 
in 27 minor groups were not studied any further.
Strains isolated from 1978 through 1989, 
the groups A and B
As seen in Figure 2, six strains in the group A, which was 
isolated from 1978 through 1989 had the type IV SCCmec 
without exception. Strains in the group B, consisting of 
38 strains, isolated in 1980–1989, showed predominantly the 
type I SCCmec with only exception of two strains.
MIC50 values were the antibiotic concentration that 
inhibits the growth of 50% of strains and the ranges were 
shown in Table 1. The MIC50 of antibiotics in the respective 
groups was determined and the results were shown in Table 2. 
The strains in the groups A and B showed   susceptibility 
to all the antibiotics tested with an exception against GM. 
These strains were collected during the period of 1980 
through 1989 and were having the type IV or type I SCCmec 
  predominantly. The strains in the group A and B were 
resistant to GM and that turned to be susceptible in the strain 
in the groups C, E, F, G, and K. The strains in the groups A 
and B were susceptible to MINO.
Strains isolated ∼1985 through 2002,  
the groups c through K
All the strains in the groups C through K isolated during the 



















































Figure 1 PFGE profiles and a phylogeny of MRSAs grouped into 11 unique DNA types. The PFGE profiles were digitized, and the degree of homology was calculated by 
the unweighted pair-group method. The DNA profiles that showed over ∼90% identity were classified into the same group. The groups of MRSA that showed unique DNA 





nine nontypeable strains. Strains in group K, isolated in 
2000–2001, had all nontypeable SCCmec by the present 
method. This seems to be understandable because the MRSAs 
in this group were isolated in the latest period during this 
study. Therefore, the strains in the group K likely had the 
new type of SCCmec. The MINO-susceptible strains were 
found in the groups C, D, F, and I and the strains in the rest 
of groups were MINO resistant.
The strains classified into the group C, which was isolated 
during the period of 1982 through 1994, suddenly became 
resistant to the β-lactam antibiotics (IPM) and this trend 
has been kept for the strains in the groups D through K with 
only an exception that strains in the group G showed IPM 
susceptibility. Strains in the groups C through K, which 
were isolated during the period of 1985 through 2002, 
showed marked resistance to CPFX, though the strains in the 
group C isolated in 1982–1994 were intermediately resistant. 
These results suggested that strong β-lactam antibiotics and 
fluoroquinolone antibiotics might be introduced for clinical 
use in this period.
The GM-resistant strains in group A and B turned out 
to be more susceptible than those strains in group C, E, F, 
and G. However, reemergence of the GM-resistant MRSAs 
in the groups C, H, I, and J suggested that GM-resistant 
clones were selected and spread within the hospital. The 
strains in the group E, G, H, J, and K were resistant to 
MINO suggesting that tetracycline derivatives might be 
used during the period for the groups G through J. The 
strains in the group C through K except the group I were 
CLDM susceptible.
Antibiotics effective against MrSA
All the strains tested showed the susceptible range of MIC50 
of ABK, RFP, ST, TEIC, VCM, and LZD, whereas they were 
resistant to IPM, GM, and CLDM according to the CLSI cri-
teria. Thus, the analysis clearly revealed that the susceptibility 
to these drugs was unrelated with the PFGE fingerprinting 
and the SCCmec types.
Discussion
PFGE is a useful method for genomic fingerprinting of micro-
organisms, and the data could be used for epidemiological 
study of virulent organisms. SCCmec typing is also used for 
the epidemiological study of MRSA.18–21 However, it might 
be difficult to use the SCCmec typing for the clonal identifi-
cation of MRSA because the SCCmec typing only analyzes 
a small fraction of the chromosome. Our investigation was 
conducted to analyze clonal identity of 218 blood-isolated 
MRSAs from 1978 through 2002, and the results were used 
for the interpretation of the origins of the strain, possible 
dissemination, and persistency in the hospital. Attempts have 
been made to link the MIC of antibiotics with the DNA types 
of the strain and SCCmec type.
The DNA typing of the strain revealed four important 
facts: 1) Three quarters of the isolates, which belonged to 
only 11 DNA types among 39, were inhabited and spread 
Group  Number  SCCmec
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Figure 2 Length and the chronology of the MrSA isolation and their Sccmec type. Length and the chronology of the MrSA isolation and their Sccmec type A through K 
represents the groups of DnA type and number represents numbers of strain belonging to each type of DnA group. The Sccmec type was given. A horizontal bar shows 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































within the hospital. 2) The strains inhabited in the hospital 
persisted for a long period of time causing the presence of 
multiple types of MRSA clones of different genotype in the 
same time. 3) Roughly, one quarter of strains were either suc-
cessfully treated or phased out. 4) Group A (SCCmec type I) 
and B (type IV) were highly susceptible to both carbapenem 
and fluoroquinolone than group C–J (type II) and group K 
(nontype). In addition, it was generally said in Japan that 
the strains resistant to less numbers of antibiotics tend to be 
SCCmec type I and IV .
It was well recognized that the recently isolated MRSAs 
from septicemia were found to have SCCmec type II.22 
  However, the result shown in Figure 2 suggested that 
septicemia in early 1980s was caused by the strain having 
SCCmec type I (group B) and IV (group A). The strains hav-
ing SCCmec type I and IV seemed to disappear from hospital 
probably because they were highly susceptible to multiple 
antibiotics except against GM. Because the SCCmec typing 
provides information mainly on β-lactam antibiotic suscep-
tibility, drastic change of the SCCmec types might be related 
to the use of β-lactam. In fact, the SCCmec type of strains in 
the group A and B has been changed largely from type IV 
and I to type II in the group C through J that is   consistent 
with the approval of carbapenem. Close examination of the 
dendrogram also showed drastic change of the DNA types 
in groups A, B, and C through K. Moreover, the CPFX 
susceptibility profile has been markedly changed between 
the strains in the group A (SCCmec type IV), B (SCCmec 
type I), and C through K (SCCmec type II and nontype) that 
is consistent with the approval of the fluoroquinolone antibi-
otics. One other thing notable in this study would be the GM 
susceptibility. The groups A and B, those isolated in the early 
phase of this study, were GM-resistant and the groups C, E, 
F, G and K turned out to be GM-susceptible. This is   probably 
due to the fact that the isolation frequency of the strain 
producing aminoglycoside-modifying enzyme decreased 
markedly.23 The GM-resistant clones reemerged again later, 
which could be interpreted in two ways: 1) the susceptible 
strain gained GM resistance, or 2) new   GM-resistant clone(s) 
were carried in from outside. Eventually, the strains resistant 
to GM, IPM, and CPFX, the multiantibiotic-resistant MRSA 
survived in the hospital.
Conclusions
The conclusions of this study are as follows: 1) SCCmec 
type had been changed from type I and IV to type II in the 
late 1980s. 2) The strains having SCCmec type I or IV were 
more susceptible to antibiotics than type II. 3) The strains 
having SCCmec type II were highly antibiotic resistant and 
therefore they could be persisted in the hospital. To eradicate 
MRSA from hospitals, a long-term usage of antimicrobial 
agents must be designed cautiously. Therefore, preventing 
the dissemination of MRSA in the hospital environments may 
be the first priority among the infection-control programs. 
Active surveillance of MRSAs, proper use of antibiotics, and 
hygienic hand-washing are recommended for prevention of 
nosocomial spread of MRSAs.
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